SONIA PERNAS SIMON

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sonia Pernas Simon is an Associate Professor at the University of Barcelona. Her research primarily focuses on breast cancer, with recent publications exploring the efficacy of various treatments, patient outcomes, and innovative clinical characterizations. She has contributed to significant studies including those on datopotamab deruxtecan and the long-term follow-up of breast cancer cohorts. Dr. Pernas Simon's work emphasizes the intersection of oncology and patient care in advanced cancer management.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Ramon Colomer

Profesor Titular

Universidad Autónoma de Madrid

SPAIN

View details

MAR VARELA

Bellvitge University Hospital

SPAIN

View details

Jan Bosch-Schips

Bellvitge University Hospital

SPAIN

View details

Pedro Moliner

SPAIN

View details

Isabel Blancas

Profesora Asociada Contratada Laboral

Universidad de Granada

SPAIN

View details

Seock-Ah Im

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

Anna Esteve

Institut Català d'Oncologia

SPAIN

View details

Maria Laplana

Institut Català d'Oncologia

SPAIN

View details

Andrea González Valencia

Institut Català d'Oncologia

SPAIN

View details

Emilio Alba Conejo

Professor

Universidad de Málaga Facultad de Medicina

SPAIN

View details

miguel quintela-fandino

Associate Professor

Universidad Autónoma de Madrid

SPAIN

View details

Joaquim Hernandez

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Xavier Gonzàlez Farré

Associate professor

Universitat Internacional de Catalunya

SPAIN

View details

Josep Comin‐Colet

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SONIA PERNAS SIMON

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d’Oncologia Breast Cancer Observational Cohort Study

RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705

High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Breast Cancer Patient’s Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II–III Disease

Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment

Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy

Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project)

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2– breast cancer

Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)

SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)

Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness

Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments

Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer

Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.

Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?

Clinical trial data and emerging strategies: HER2-positive breast cancer

Metformin and Breast Cancer: Where Are We Now?

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.

Collaborators (14)

Ramon Colomer

MAR VARELA

Jan Bosch-Schips

Pedro Moliner

Isabel Blancas

Seock-Ah Im

Anna Esteve

Maria Laplana

Andrea González Valencia

Emilio Alba Conejo

miguel quintela-fandino

Joaquim Hernandez

Xavier Gonzàlez Farré

Josep Comin‐Colet

Make your next move.